12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Venus Concept (NASDAQ:VERO) shares rose 87.9% to $1.1 during Friday’s regular session. The company’s market cap stands…
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Novo Integrated Sciences (NASDAQ:NVOS) shares rose 120.0% to $0.99 during Friday’s regular session. The company’s market cap…
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The company's primary focus is on developing therapy for acute cannabinoid intoxication (ACI).Total operating expenses in the second quarter of fiscal 2024 were $2.8 million compared with $3.8 million in the same period in fiscal 2023.Net loss in the second quarter of fiscal 2024 was $2.7 million, or $(0.11) per share, compared with a net loss of $3.8 million, or $(0.15) per share, in the second quarter of fiscal 2023.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 73.2% to $0.98 during Thursday’s regular session. The market value…
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 122.3% to $3.29 during Tuesday’s regular session. Nkarta’s stock is trading…
Benzinga’s Top Ratings Upgrades, Downgrades For September 18, 2023
Upgrades Northcoast Research upgraded the previous rating for Jack Henry & Associates Inc (NASDAQ:JKHY) from Neutral to Buy.…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Axcella Health (NASDAQ:AXLA) shares increased by 59.1% to $0.28 during Tuesday’s pre-market session. The company’s market cap…
Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid Intoxication
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced positive feedback from the United States Food and Drug Administration following a type B meeting in July.